Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vento

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
HIV Medicine|March 19, 2010
Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapyE Lattuada, A Vallone, M Lanzafame, et al.
AIDS Care|August 27, 2005
Recreational substance use and tolerance of efavirenz in HIV-1 infected patientsF Faggian, E Lattuada, M Lanzafame, et al.
Diabetes Care|July 15, 2000
Coxsackie B virus-induced autoimmunity to GAD does not lead to type 1 diabetesF Cainelli, D Manzaroli, C Renzini, et al.
The Journal of Antimicrobial Chemotherapy|May 13, 1998
Fluconazole penetration into the prostatic fluid of patients with AIDS-associated cryptococcal meningitisR Luzzati, G Gatti, L Lazzarini, et al.
Chest|September 24, 1999
Mediastinal lymphadenitis due to cryptococcal infection in HIV-positive patients on highly active antiretroviral therapyM Lanzafame, M Trevenzoli, G Carretta, et al.
The British Journal of Dermatology|August 2, 2003
Unusual, rapidly growing ulcerative genital mass due to herpes simplex virus in a human immunodeficiency virus-infected womanM Lanzafame, R Mazzi, C Di Pace, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 1992
Use of fluconazole in the treatment of Candida albicans hydrocephalus shunt infectionM Cruciani, G Di Perri, M Molesini, et al.
Lancet (London, England)|April 10, 1993
Rapid decline of CD4+ cells after IFN alpha treatment in HIV-1 infectionS Vento, G Di Perri, M Cruciani, et al.
Lancet (London, England)|April 14, 1990
Type 2 autoimmune hepatitis and hepatitis C virus infectionS Vento, G Di Perri, R Luzzati, et al.
Lancet (London, England)|May 18, 1991
Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individualsS Vento, T Garofano, G Di Perri, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
HIV Medicine|March 19, 2010
Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapyE Lattuada, A Vallone, M Lanzafame, et al.
AIDS Care|August 27, 2005
Recreational substance use and tolerance of efavirenz in HIV-1 infected patientsF Faggian, E Lattuada, M Lanzafame, et al.
Diabetes Care|July 15, 2000
Coxsackie B virus-induced autoimmunity to GAD does not lead to type 1 diabetesF Cainelli, D Manzaroli, C Renzini, et al.
The Journal of Antimicrobial Chemotherapy|May 13, 1998
Fluconazole penetration into the prostatic fluid of patients with AIDS-associated cryptococcal meningitisR Luzzati, G Gatti, L Lazzarini, et al.
Chest|September 24, 1999
Mediastinal lymphadenitis due to cryptococcal infection in HIV-positive patients on highly active antiretroviral therapyM Lanzafame, M Trevenzoli, G Carretta, et al.
The British Journal of Dermatology|August 2, 2003
Unusual, rapidly growing ulcerative genital mass due to herpes simplex virus in a human immunodeficiency virus-infected womanM Lanzafame, R Mazzi, C Di Pace, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 1, 1992
Use of fluconazole in the treatment of Candida albicans hydrocephalus shunt infectionM Cruciani, G Di Perri, M Molesini, et al.
Lancet (London, England)|April 10, 1993
Rapid decline of CD4+ cells after IFN alpha treatment in HIV-1 infectionS Vento, G Di Perri, M Cruciani, et al.
Lancet (London, England)|April 14, 1990
Type 2 autoimmune hepatitis and hepatitis C virus infectionS Vento, G Di Perri, R Luzzati, et al.
Lancet (London, England)|May 18, 1991
Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individualsS Vento, T Garofano, G Di Perri, et al.
Pageof 11